KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBT Margin (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed EBT Margin for 16 consecutive years, with 612.3% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, EBT Margin fell 62829.0% year-over-year to 612.3%, compared with a TTM value of 22.58% through Dec 2024, up 788.0%, and an annual FY2025 reading of 515.01%, down 875.0% over the prior year.
  • EBT Margin was 612.3% for Q4 2024 at Thermo Fisher Scientific, down from 16.44% in the prior quarter.
  • Across five years, EBT Margin topped out at 27.79% in Q2 2021 and bottomed at 612.3% in Q4 2024.
  • Average EBT Margin over 5 years is 12.98%, with a median of 16.72% recorded in 2023.
  • The sharpest move saw EBT Margin skyrocketed 1450bps in 2021, then plummeted -62829bps in 2024.
  • Year by year, EBT Margin stood at 27.46% in 2020, then crashed by -37bps to 17.4% in 2021, then dropped by -11bps to 15.52% in 2022, then grew by 3bps to 15.98% in 2023, then plummeted by -3931bps to 612.3% in 2024.
  • Business Quant data shows EBT Margin for TMO at 612.3% in Q4 2024, 16.44% in Q3 2024, and 16.74% in Q2 2024.